Centre forms committee to examine WHO details on 66 kid deaths in The Gambia
Darpan News Desk IANS, 12 Oct, 2022 11:00 AM
New Delhi, Oct 12 (IANS) The Centre has formed a four-member panel to examine the detailed report shared by the World Health Organisation on 66 children's deaths in The Gambia reportedly after using Indian-made medicines.
"The committee will examining and analysing adverse event reports, causal relationship, and all related details shared by WHO. After examining, the committee will suitably advise and recommend the Drug Controller General of India (DCGI) about further course of action. The committee may co-opt any other technical expert as deemed necessary, an official source told IANS.
The WHO had issued an alert on four India-made cough and cold syrups "potentially linked with acute kidney injuries and 66 deaths among children in Gambia".
The committee will be chaired by Dr Y.K Gupta, Vice Chairperson, Standing National Committee on Medicines. The other members are Dr Pragya D. Yadav, NIV, ICMR, Pune, Dr Arti Bahl, Division of Epidemiology, NCDC, New Delhi, and A.K. Pradhan, JDC(I), CDSCO.
The WHO has informed that as per the tentative results received by it, out of the 23 samples of the products under reference which were tested, four samples have been found to contain Diethylene Glycol/Ethylene Glycol.
However, the global health body has not yet made available the certificate of analysis. It has informed that the same will be made available in near future. The exact one to one causal relation of death has not yet been provided by the WHO to the Central Drugs Standard Control Organisation (CDSCO) although it has requested the global health body twice in this regard, sources told IANS.
After the CDSCO launched a detailed investigation to ascertain the facts, the preliminary enquiry has revealed that Maiden Pharmaceutical Ltd, Sonepat, Haryana is a manufacturer licensed by the State Drug Controller for products Promethazine Oral Solution BP, Kofexnalin Baby Cough Syrup, MaKoff Baby Cough Syrup, and MaGrip n Cold Syrup under reference, and holds manufacturing permission for these products for export only. The company has manufactured and exported these products only to The Gambia.
Meanwhile, the CDSCO and State Drug Controller Haryana have stopped all the manufacturing activities of Maiden Pharmaceuticals Ltd at Sonepat on October 11 on grounds of deficiencies found on local inspection.
In a daze the victim handed over her gold locket and a pair of golden tops to the accused. When she regained her senses she called the police. Based on her complaint, the police registered a case under sections 420 and 34 of the Indian Penal Code.
In regulatory filing, Reliance Jio, the telecom arm of the Reliance group, said the Board of Directors at its meeting held on Monday "approved the appointment of Akash Ambani, Non-executive Director, as the Chairman of the Board of Directors of the company".
Senior Superintendent of Police (SSP) Mohali, Vivek Sheel Soni, on Tuesday ordered registration of an FIR against Sub-Inspector (S-I) Balwinder Singh in the firing incident in Dera Bassi in Punjab. The SSP also initiated departmental action against three police personnel present at the spot for major punishment.
Punjab Chief Minister Bhagwant Mann on Tuesday informed the Assembly that the state will soon bring a resolution in the House to oppose the Centre's Agnipath scheme regarding the defence recruitment. Also, he said, a resolution on condemning the ban on Sidhu Moosewala's new song, SYL, on YouTube.
The Special Cell sought fourteen days police custody. The police move was opposed by advocate Deepak Tyagi who appeared for Kumar. The court after hearing the arguments allowed the police request and sent him to police custody.
In a statement released here, Sirsa said he had claimed from day one that the excise policy of Delhi and now of Punjab has been framed to benefit large contractors from whom the AAP wanted to get election funds to contest elections in time to come in Himachal Pradesh and Gujarat.
